Michael D. Rosu-Myles, Ph.D.
Affiliations: | 2004 | The University of Western Ontario (Canada) |
Area:
Cell BiologyGoogle:
"Michael Rosu-Myles"Parents
Sign in to add mentor| Mickie Bhatia | grad student | 2004 | The University of Western Ontario (Canada) | |
| (Characterization of CXCR4 and SDF-1 in hematopoietic stem and progenitor cell function.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gobin J, Muradia G, Mehic J, et al. (2021) Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell. Stem Cell Research & Therapy. 12: 127 |
| Munshi A, Mehic J, Creskey M, et al. (2019) A comprehensive proteomics profiling identifies NRP1 as a novel identity marker of human bone marrow mesenchymal stromal cell-derived small extracellular vesicles. Stem Cell Research & Therapy. 10: 401 |
| Aldreiwish A, Muradia G, Gagne R, et al. (2019) "Identification of Mechanisms By Which Mesenchymal Stem/Stromal Cells Contribute to Acute Myeloid Leukemia" Blood. 134: 5194-5194 |
| Díaz de la Guardia R, Lopez-Millan B, Roca-Ho H, et al. (2018) Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis. Haematologica |
| Munshi A, Rigg E, Mehic J, et al. (2018) Comparative study of hypoxic and normoxic preconditioned mesenchymal stem cell derived extracellular vesicles and their therapeutic implications Cytotherapy. 20: S23 |
| Lavoie J, Rigg E, Munshi A, et al. (2018) Characterization of leukemia-derived extracellular vesicles and subsequent effects on mesenchymal stem cell phenotype Cytotherapy. 20: S22 |
| Diaz de la Guardia R, Lopez-Millan B, Lavoie JR, et al. (2017) Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes. Stem Cell Reports |
| Lavoie JR, Creskey MC, Muradia G, et al. (2016) EMILIN-1 and ILK are Novel Markers of Islet Regenerative Function in Human Multipotent Mesenchymal Stromal Cells. Stem Cells (Dayton, Ohio) |
| Lavoie J, Kunkel J, Saba J, et al. (2016) Generation of Quantitative Proteomic and Glycoproteomic Profiles Specific to Transformed Mesenchymal Stem Cells Cytotherapy. 18: S24 |
| Lavoie J, Rodriguez R, Kunkel J, et al. (2016) Candidate biomarkers of transformed mesenchymal stromal/stem cells by quantitative proteomics and glycoproteomics Experimental Hematology. 44: S86-S87 |